Literature DB >> 22726818

Central apnea at complex partial seizure onset.

Mangala A Nadkarni1, Daniel Friedman, Orrin Devinsky.   

Abstract

Sudden Unexpected Death in Epilepsy (SUDEP) is the most common cause of epilepsy related mortality in treatment resistant epilepsy. Most SUDEPs occur after one or more seizure(s) during sleep. Nocturnal seizures may go unrecognized. Respiratory depression in the peri-ictal period is one of the primary potential causes of SUDEP. Ictal and postictal apnea is often overlooked because it is not routinely assessed, but appears common and has been a recent focus of SUDEP research. We report a 37 year-old man who had central apnea as the initial manifestation of partial complex seizures associated with oxygen desaturation. This important pathophysiological consequence of a nocturnal complex seizure was identified by respiratory monitoring during a combined video EEG and sleep study. Diagnostic and therapeutic implications are discussed.
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22726818     DOI: 10.1016/j.seizure.2012.04.001

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  3 in total

1.  Amygdala and hippocampus are symptomatogenic zones for central apneic seizures.

Authors:  Nuria Lacuey; Bilal Zonjy; Luisa Londono; Samden D Lhatoo
Journal:  Neurology       Date:  2017-01-13       Impact factor: 9.910

Review 2.  Wearable Fiber Optic Technology Based on Smart Textile: A Review.

Authors:  Zidan Gong; Ziyang Xiang; Xia OuYang; Jun Zhang; Newman Lau; Jie Zhou; Chi Chiu Chan
Journal:  Materials (Basel)       Date:  2019-10-11       Impact factor: 3.623

3.  Electrical Stimulation-Induced Seizures and Breathing Dysfunction: A Systematic Review of New Insights Into the Epileptogenic and Symptomatogenic Zones.

Authors:  Manuela Ochoa-Urrea; Mojtaba Dayyani; Behnam Sadeghirad; Nitin Tandon; Nuria Lacuey; Samden D Lhatoo
Journal:  Front Hum Neurosci       Date:  2021-01-22       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.